Related Experiment Video
Updated: Jul 4, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Thrombocytopenia in HCV infection. Natural interferon as an alternative therapy]
Joanna Krzowska-Firych1, Roma Modrzewska, Sławomir Grzegorz Kiciak
1Katedra i Klinika Chorób Zakaźnych Akademii Medycznej im. prof. F. Skubiszewskiego w Lublinie. firychjdr@poczta.onet.pl
The current standard of care for the treatment of hepatitis C virus (HCV) infection is the combination of pegylated interferon and ribavirin. The interferon-based therapy is contraindicated in patients with HCV-associated thrombocytopenia. The pathogenesis of HCV-associated thrombocytopenia is still unclear. In this paper the main aspects of HCV-associated thrombocytopenia and alternative therapy with natural interferon (Alfaferone) are presented.
The current standard of care for the treatment of hepatitis C virus (HCV) infection is the combination of pegylated interferon and ribavirin. The interferon-based therapy is contraindicated in patients with HCV-associated thrombocytopenia. The pathogenesis of HCV-associated thrombocytopenia is still unclear. In this paper the main aspects of HCV-associated thrombocytopenia and alternative therapy with natural interferon (Alfaferone) are presented.
More Related Videos
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Venous Thrombosis III: Interprofessional Care
Hepatitis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Viral Hepatitis I: Introduction
Inhibitors Of Virion Release

